Cost-effectiveness of oral treatments for chronic hepatitis B

被引：2
|
作者：
Dusheiko, Geoffrey M. [1 ,2 ]
机构：
[1] Royal Free Hosp, Ctr Hepatol, London NW3 2QG, England
[2] UCL, Sch Med, London NW3 2QG, England
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 51卷 / 04期
关键词：
ADEFOVIR DIPIVOXIL; LAMIVUDINE;
D O I：
10.1016/j.jhep.2009.07.015
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：623 / 625
页数：3
相关论文
共 50 条
  • [1] EVALUATION OF COST-EFFECTIVENESS OF CHRONIC HEPATITIS B TREATMENTS: ENTECAVIR AND TELBIVUDINE
    Suh, J. K.
    Hay, J.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A72 - A72
  • [2] Application of Bayesian Approach to Cost-Effectiveness Analysis of Antiviral Treatments in Chronic Hepatitis B
    Zhang, Hua
    Huo, Mingdong
    Chao, Jianqian
    Liu, Pei
    [J]. PLOS ONE, 2016, 11 (08):
  • [3] Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B
    Buti, Maria
    Brosa, Max
    Casado, Miguel A.
    Rueda, Magdalena
    Esteban, Rafael
    [J]. JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 640 - 646
  • [4] A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B
    Spackman, D. Eldon
    Veenstra, David L.
    [J]. PHARMACOECONOMICS, 2008, 26 (11) : 937 - 949
  • [5] A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B
    D. Eldon Spackman
    David L. Veenstra
    [J]. PharmacoEconomics, 2008, 26 : 937 - 949
  • [6] Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada
    He, Jing
    Bowen, James M.
    Xie, Feng
    Goeree, Ron
    [J]. VALUE IN HEALTH, 2012, 15 (06) : 894 - 906
  • [7] Cost-effectiveness in hepatitis B
    Weitzman, G
    Jacobson, I
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 143 (10) : 757 - 758
  • [8] Cost-effectiveness of lamivudine for the treatment of chronic hepatitis B in Canada
    Haiderali, AM
    Villa, K
    Schrammel, P
    [J]. HEPATOLOGY, 1999, 30 (04) : 347A - 347A
  • [9] Cost-effectiveness analysis of lamivudine for the treatment of chronic hepatitis B
    Crowley, SJ
    Tognarini, D
    Desmond, PV
    Lees, M
    [J]. PHARMACOECONOMICS, 2000, 17 (05) : 409 - 427
  • [10] Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
    Wong, J. B.
    Pauker, S. G.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 : S199 - S199
12345